Sulfonated phenolics/sulfuric acid
This article needs additional citations for verification. (January 2011) (Learn how and when to remove this template message)
|Sulfuric acid||Mineral acid|
|Sulfonated phenolics||Sulfonic acid|
|(what is this?)|
Sulfonated phenolics/sulfuric acid is not listed in the Physician's Desk Reference and has not been approved by the Food and Drug Administration for any indication. Debacterol is not an antiseptic or topical anesthetic but rather a chemical cautery agent that destroy cells at the application site, including nerve endings that transmit pain.
One clinical trial comparing Debacterol to Kenalog-in-Orabase and a no-intervention control group found that patients treated with sulfonated phenolics/sulfuric acid reported significantly better relief of symptoms compared to the other two groups three days after treatment. In the same study, 60 percent of ulcers treated with Debacterol had disappeared by day six compared to about 30 percent in the other treatment groups.
Sulfonated phenolics/sulfuric acid appears to be more effective on sores in areas of the mouth that produce less saliva. Since a sore must be dry prior to application of Debacterol, it is difficult to properly apply under the tongue. The duration of pain relief and the overall effectiveness may be reduced in such areas.
- "Debacterol product description".
- "PDR.Net (The Physician's Desk Reference)". www.pdr.net. Retrieved 2018-04-04.
- "Search Results: debacterol". google2.fda.gov. Retrieved 2018-04-04.
- Rhodus NL, Bereuter J (December 1998). "An evaluation of a chemical cautery agent and an anti-inflammatory ointment for the treatment of recurrent aphthous stomatitis: a pilot study". Quintessence International. 29 (12): 769–73. PMID 10196853.